nodes	percent_of_prediction	percent_of_DWPC	metapath
Valsartan—ALB—primary biliary cirrhosis	0.615	1	CbGaD
Valsartan—SLCO1B1—Drug Induction of Bile Acid Pathway—SLC51B—primary biliary cirrhosis	0.0132	0.106	CbGpPWpGaD
Valsartan—SLCO1B1—Drug Induction of Bile Acid Pathway—SLC51A—primary biliary cirrhosis	0.01	0.0801	CbGpPWpGaD
Valsartan—AGTR1—ACE Inhibitor Pathway—MAS1—primary biliary cirrhosis	0.00983	0.0785	CbGpPWpGaD
Valsartan—AGTR1—ACE Inhibitor Pathway—ACE2—primary biliary cirrhosis	0.00745	0.0595	CbGpPWpGaD
Valsartan—AGTR1—ACE Inhibitor Pathway—REN—primary biliary cirrhosis	0.00565	0.0451	CbGpPWpGaD
Valsartan—SLCO1B1—Codeine and Morphine Metabolism—ABCC2—primary biliary cirrhosis	0.00553	0.0442	CbGpPWpGaD
Valsartan—Rhabdomyolysis—Colchicine—primary biliary cirrhosis	0.00389	0.0153	CcSEcCtD
Valsartan—SLCO1B1—Irinotecan Pathway—ABCC2—primary biliary cirrhosis	0.00354	0.0282	CbGpPWpGaD
Valsartan—AGTR1—ACE Inhibitor Pathway—ACE—primary biliary cirrhosis	0.00352	0.0281	CbGpPWpGaD
Valsartan—Viral infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.00343	0.0135	CcSEcCtD
Valsartan—Viral infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.00343	0.0135	CcSEcCtD
Valsartan—Drug interaction—Ursodeoxycholic acid—primary biliary cirrhosis	0.00334	0.0131	CcSEcCtD
Valsartan—Drug interaction—Chenodeoxycholic acid—primary biliary cirrhosis	0.00334	0.0131	CcSEcCtD
Valsartan—Hepatic enzyme increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00327	0.0128	CcSEcCtD
Valsartan—Hepatic enzyme increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00327	0.0128	CcSEcCtD
Valsartan—SLCO1B1—Drug Induction of Bile Acid Pathway—ABCC2—primary biliary cirrhosis	0.00303	0.0242	CbGpPWpGaD
Valsartan—SLCO1B1—Irinotecan Pathway—ABCG2—primary biliary cirrhosis	0.00301	0.024	CbGpPWpGaD
Valsartan—Olmesartan—ABCC2—primary biliary cirrhosis	0.00296	0.601	CrCbGaD
Valsartan—Photosensitivity—Ursodeoxycholic acid—primary biliary cirrhosis	0.00256	0.01	CcSEcCtD
Valsartan—Photosensitivity—Chenodeoxycholic acid—primary biliary cirrhosis	0.00256	0.01	CcSEcCtD
Valsartan—Atrial fibrillation—Chenodeoxycholic acid—primary biliary cirrhosis	0.00237	0.00931	CcSEcCtD
Valsartan—Atrial fibrillation—Ursodeoxycholic acid—primary biliary cirrhosis	0.00237	0.00931	CcSEcCtD
Valsartan—Renal impairment—Ursodeoxycholic acid—primary biliary cirrhosis	0.00236	0.00927	CcSEcCtD
Valsartan—Renal impairment—Chenodeoxycholic acid—primary biliary cirrhosis	0.00236	0.00927	CcSEcCtD
Valsartan—Blood creatinine increased—Colchicine—primary biliary cirrhosis	0.00234	0.0092	CcSEcCtD
Valsartan—Cardiac failure—Chenodeoxycholic acid—primary biliary cirrhosis	0.0023	0.00904	CcSEcCtD
Valsartan—Cardiac failure—Ursodeoxycholic acid—primary biliary cirrhosis	0.0023	0.00904	CcSEcCtD
Valsartan—Cramp muscle—Colchicine—primary biliary cirrhosis	0.00225	0.00884	CcSEcCtD
Valsartan—AGTR1—ACE Inhibitor Pathway—AGT—primary biliary cirrhosis	0.00223	0.0178	CbGpPWpGaD
Valsartan—Muscular weakness—Colchicine—primary biliary cirrhosis	0.00221	0.00866	CcSEcCtD
Valsartan—SLCO1B3—Transport of organic anions—ALB—primary biliary cirrhosis	0.00212	0.0169	CbGpPWpGaD
Valsartan—Blood creatinine increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00211	0.00826	CcSEcCtD
Valsartan—Blood creatinine increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00211	0.00826	CcSEcCtD
Valsartan—Abdominal pain upper—Chenodeoxycholic acid—primary biliary cirrhosis	0.00205	0.00806	CcSEcCtD
Valsartan—Abdominal pain upper—Ursodeoxycholic acid—primary biliary cirrhosis	0.00205	0.00806	CcSEcCtD
Valsartan—Orthostatic hypotension—Chenodeoxycholic acid—primary biliary cirrhosis	0.00205	0.00806	CcSEcCtD
Valsartan—Orthostatic hypotension—Ursodeoxycholic acid—primary biliary cirrhosis	0.00205	0.00806	CcSEcCtD
Valsartan—Cramp muscle—Ursodeoxycholic acid—primary biliary cirrhosis	0.00202	0.00794	CcSEcCtD
Valsartan—Cramp muscle—Chenodeoxycholic acid—primary biliary cirrhosis	0.00202	0.00794	CcSEcCtD
Valsartan—AGTR1—Peptide GPCRs—CXCR5—primary biliary cirrhosis	0.00202	0.0161	CbGpPWpGaD
Valsartan—Neutropenia—Colchicine—primary biliary cirrhosis	0.00202	0.00794	CcSEcCtD
Valsartan—AGTR1—Allograft Rejection—CXCR5—primary biliary cirrhosis	0.00192	0.0153	CbGpPWpGaD
Valsartan—Bronchitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00187	0.00733	CcSEcCtD
Valsartan—Bronchitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00187	0.00733	CcSEcCtD
Valsartan—Upper respiratory tract infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.00181	0.00709	CcSEcCtD
Valsartan—Upper respiratory tract infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.00181	0.00709	CcSEcCtD
Valsartan—Photosensitivity reaction—Chenodeoxycholic acid—primary biliary cirrhosis	0.00177	0.00696	CcSEcCtD
Valsartan—Photosensitivity reaction—Ursodeoxycholic acid—primary biliary cirrhosis	0.00177	0.00696	CcSEcCtD
Valsartan—AGTR1—Allograft Rejection—CXCL9—primary biliary cirrhosis	0.00174	0.0139	CbGpPWpGaD
Valsartan—Infestation—Chenodeoxycholic acid—primary biliary cirrhosis	0.00173	0.0068	CcSEcCtD
Valsartan—Infestation NOS—Chenodeoxycholic acid—primary biliary cirrhosis	0.00173	0.0068	CcSEcCtD
Valsartan—Infestation NOS—Ursodeoxycholic acid—primary biliary cirrhosis	0.00173	0.0068	CcSEcCtD
Valsartan—Infestation—Ursodeoxycholic acid—primary biliary cirrhosis	0.00173	0.0068	CcSEcCtD
Valsartan—Renal failure—Ursodeoxycholic acid—primary biliary cirrhosis	0.0017	0.00668	CcSEcCtD
Valsartan—Renal failure—Chenodeoxycholic acid—primary biliary cirrhosis	0.0017	0.00668	CcSEcCtD
Valsartan—AGTR1—Allograft Rejection—IL12A—primary biliary cirrhosis	0.0017	0.0135	CbGpPWpGaD
Valsartan—Epistaxis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00163	0.00641	CcSEcCtD
Valsartan—Epistaxis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00163	0.00641	CcSEcCtD
Valsartan—Sinusitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00162	0.00638	CcSEcCtD
Valsartan—Sinusitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00162	0.00638	CcSEcCtD
Valsartan—SLCO1B3—Recycling of bile acids and salts—ALB—primary biliary cirrhosis	0.00157	0.0125	CbGpPWpGaD
Valsartan—Haemoglobin—Ursodeoxycholic acid—primary biliary cirrhosis	0.00156	0.00613	CcSEcCtD
Valsartan—Haemoglobin—Chenodeoxycholic acid—primary biliary cirrhosis	0.00156	0.00613	CcSEcCtD
Valsartan—Mediastinal disorder—Colchicine—primary biliary cirrhosis	0.00156	0.00612	CcSEcCtD
Valsartan—Rhinitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00156	0.00612	CcSEcCtD
Valsartan—Rhinitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00156	0.00612	CcSEcCtD
Valsartan—Haemorrhage—Ursodeoxycholic acid—primary biliary cirrhosis	0.00155	0.0061	CcSEcCtD
Valsartan—Haemorrhage—Chenodeoxycholic acid—primary biliary cirrhosis	0.00155	0.0061	CcSEcCtD
Valsartan—Pharyngitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00154	0.00606	CcSEcCtD
Valsartan—Pharyngitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00154	0.00606	CcSEcCtD
Valsartan—Urinary tract disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00154	0.00603	CcSEcCtD
Valsartan—Urinary tract disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00154	0.00603	CcSEcCtD
Valsartan—Alopecia—Colchicine—primary biliary cirrhosis	0.00153	0.006	CcSEcCtD
Valsartan—Connective tissue disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00153	0.006	CcSEcCtD
Valsartan—Connective tissue disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00153	0.006	CcSEcCtD
Valsartan—Urethral disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00152	0.00598	CcSEcCtD
Valsartan—Urethral disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00152	0.00598	CcSEcCtD
Valsartan—Malnutrition—Colchicine—primary biliary cirrhosis	0.00151	0.00591	CcSEcCtD
Valsartan—Muscle spasms—Colchicine—primary biliary cirrhosis	0.00145	0.00569	CcSEcCtD
Valsartan—Cardiac disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00144	0.00566	CcSEcCtD
Valsartan—Cardiac disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00144	0.00566	CcSEcCtD
Valsartan—SLCO1B1—Transport of organic anions—ALB—primary biliary cirrhosis	0.00142	0.0114	CbGpPWpGaD
Valsartan—Angiopathy—Chenodeoxycholic acid—primary biliary cirrhosis	0.00141	0.00554	CcSEcCtD
Valsartan—Angiopathy—Ursodeoxycholic acid—primary biliary cirrhosis	0.00141	0.00554	CcSEcCtD
Valsartan—Immune system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.0014	0.00551	CcSEcCtD
Valsartan—Immune system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.0014	0.00551	CcSEcCtD
Valsartan—Mediastinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.0014	0.0055	CcSEcCtD
Valsartan—Mediastinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.0014	0.0055	CcSEcCtD
Valsartan—Losartan—ACE—primary biliary cirrhosis	0.0014	0.283	CrCbGaD
Valsartan—Angioedema—Colchicine—primary biliary cirrhosis	0.00138	0.0054	CcSEcCtD
Valsartan—Alopecia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00137	0.00539	CcSEcCtD
Valsartan—Alopecia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00137	0.00539	CcSEcCtD
Valsartan—Malnutrition—Ursodeoxycholic acid—primary biliary cirrhosis	0.00135	0.00531	CcSEcCtD
Valsartan—Malnutrition—Chenodeoxycholic acid—primary biliary cirrhosis	0.00135	0.00531	CcSEcCtD
Valsartan—Flatulence—Ursodeoxycholic acid—primary biliary cirrhosis	0.00133	0.00524	CcSEcCtD
Valsartan—Flatulence—Chenodeoxycholic acid—primary biliary cirrhosis	0.00133	0.00524	CcSEcCtD
Valsartan—Back pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00131	0.00514	CcSEcCtD
Valsartan—Back pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00131	0.00514	CcSEcCtD
Valsartan—Muscle spasms—Chenodeoxycholic acid—primary biliary cirrhosis	0.0013	0.00511	CcSEcCtD
Valsartan—Muscle spasms—Ursodeoxycholic acid—primary biliary cirrhosis	0.0013	0.00511	CcSEcCtD
Valsartan—Arthralgia—Colchicine—primary biliary cirrhosis	0.00128	0.00503	CcSEcCtD
Valsartan—Myalgia—Colchicine—primary biliary cirrhosis	0.00128	0.00503	CcSEcCtD
Valsartan—SLCO1B3—SLC-mediated transmembrane transport—SLC4A2—primary biliary cirrhosis	0.00128	0.0102	CbGpPWpGaD
Valsartan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—primary biliary cirrhosis	0.00124	0.00988	CbGpPWpGaD
Valsartan—Angioedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.00124	0.00485	CcSEcCtD
Valsartan—Angioedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.00124	0.00485	CcSEcCtD
Valsartan—Vertigo—Chenodeoxycholic acid—primary biliary cirrhosis	0.00122	0.00477	CcSEcCtD
Valsartan—Vertigo—Ursodeoxycholic acid—primary biliary cirrhosis	0.00122	0.00477	CcSEcCtD
Valsartan—Syncope—Ursodeoxycholic acid—primary biliary cirrhosis	0.00121	0.00476	CcSEcCtD
Valsartan—Syncope—Chenodeoxycholic acid—primary biliary cirrhosis	0.00121	0.00476	CcSEcCtD
Valsartan—Shock—Colchicine—primary biliary cirrhosis	0.00121	0.00475	CcSEcCtD
Valsartan—Nervous system disorder—Colchicine—primary biliary cirrhosis	0.00121	0.00473	CcSEcCtD
Valsartan—Thrombocytopenia—Colchicine—primary biliary cirrhosis	0.0012	0.00473	CcSEcCtD
Valsartan—Palpitations—Chenodeoxycholic acid—primary biliary cirrhosis	0.0012	0.0047	CcSEcCtD
Valsartan—Palpitations—Ursodeoxycholic acid—primary biliary cirrhosis	0.0012	0.0047	CcSEcCtD
Valsartan—Skin disorder—Colchicine—primary biliary cirrhosis	0.00119	0.00469	CcSEcCtD
Valsartan—Loss of consciousness—Ursodeoxycholic acid—primary biliary cirrhosis	0.00119	0.00467	CcSEcCtD
Valsartan—Loss of consciousness—Chenodeoxycholic acid—primary biliary cirrhosis	0.00119	0.00467	CcSEcCtD
Valsartan—Cough—Ursodeoxycholic acid—primary biliary cirrhosis	0.00118	0.00464	CcSEcCtD
Valsartan—Cough—Chenodeoxycholic acid—primary biliary cirrhosis	0.00118	0.00464	CcSEcCtD
Valsartan—Chest pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00115	0.00452	CcSEcCtD
Valsartan—Arthralgia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00115	0.00452	CcSEcCtD
Valsartan—Myalgia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00115	0.00452	CcSEcCtD
Valsartan—Chest pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00115	0.00452	CcSEcCtD
Valsartan—Myalgia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00115	0.00452	CcSEcCtD
Valsartan—Arthralgia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00115	0.00452	CcSEcCtD
Valsartan—Hypotension—Colchicine—primary biliary cirrhosis	0.00115	0.00451	CcSEcCtD
Valsartan—Unspecified disorder of skin and subcutaneous tissue—Ursodeoxycholic acid—primary biliary cirrhosis	0.00114	0.00449	CcSEcCtD
Valsartan—Unspecified disorder of skin and subcutaneous tissue—Chenodeoxycholic acid—primary biliary cirrhosis	0.00114	0.00449	CcSEcCtD
Valsartan—Dry mouth—Ursodeoxycholic acid—primary biliary cirrhosis	0.00113	0.00442	CcSEcCtD
Valsartan—Dry mouth—Chenodeoxycholic acid—primary biliary cirrhosis	0.00113	0.00442	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Colchicine—primary biliary cirrhosis	0.00112	0.0044	CcSEcCtD
Valsartan—AGTR1—GPCRs, Class A Rhodopsin-like—MAS1—primary biliary cirrhosis	0.00112	0.00891	CbGpPWpGaD
Valsartan—Oedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.0011	0.00434	CcSEcCtD
Valsartan—Oedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.0011	0.00434	CcSEcCtD
Valsartan—Infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.0011	0.00431	CcSEcCtD
Valsartan—Infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.0011	0.00431	CcSEcCtD
Valsartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—RPS6KB1—primary biliary cirrhosis	0.00109	0.00872	CbGpPWpGaD
Valsartan—Shock—Chenodeoxycholic acid—primary biliary cirrhosis	0.00109	0.00427	CcSEcCtD
Valsartan—Shock—Ursodeoxycholic acid—primary biliary cirrhosis	0.00109	0.00427	CcSEcCtD
Valsartan—Nervous system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00108	0.00425	CcSEcCtD
Valsartan—Nervous system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00108	0.00425	CcSEcCtD
Valsartan—Thrombocytopenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00108	0.00425	CcSEcCtD
Valsartan—Thrombocytopenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00108	0.00425	CcSEcCtD
Valsartan—Skin disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00107	0.00421	CcSEcCtD
Valsartan—Skin disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00107	0.00421	CcSEcCtD
Valsartan—Decreased appetite—Colchicine—primary biliary cirrhosis	0.00107	0.0042	CcSEcCtD
Valsartan—AGTR1—Allograft Rejection—IL12B—primary biliary cirrhosis	0.00106	0.0085	CbGpPWpGaD
Valsartan—Gastrointestinal disorder—Colchicine—primary biliary cirrhosis	0.00106	0.00417	CcSEcCtD
Valsartan—Fatigue—Colchicine—primary biliary cirrhosis	0.00106	0.00416	CcSEcCtD
Valsartan—SLCO1B1—Recycling of bile acids and salts—ALB—primary biliary cirrhosis	0.00106	0.00842	CbGpPWpGaD
Valsartan—Anorexia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00105	0.00413	CcSEcCtD
Valsartan—Anorexia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00105	0.00413	CcSEcCtD
Valsartan—Hypotension—Chenodeoxycholic acid—primary biliary cirrhosis	0.00103	0.00405	CcSEcCtD
Valsartan—Hypotension—Ursodeoxycholic acid—primary biliary cirrhosis	0.00103	0.00405	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.00101	0.00395	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.00101	0.00395	CcSEcCtD
Valsartan—Gastrointestinal pain—Colchicine—primary biliary cirrhosis	0.00101	0.00395	CcSEcCtD
Valsartan—AGTR1—Allograft Rejection—CTLA4—primary biliary cirrhosis	0.001	0.00799	CbGpPWpGaD
Valsartan—Insomnia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000999	0.00392	CcSEcCtD
Valsartan—Insomnia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000999	0.00392	CcSEcCtD
Valsartan—Paraesthesia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000992	0.00389	CcSEcCtD
Valsartan—Paraesthesia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000992	0.00389	CcSEcCtD
Valsartan—Dyspnoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000985	0.00387	CcSEcCtD
Valsartan—Dyspnoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000985	0.00387	CcSEcCtD
Valsartan—Somnolence—Chenodeoxycholic acid—primary biliary cirrhosis	0.000982	0.00385	CcSEcCtD
Valsartan—Somnolence—Ursodeoxycholic acid—primary biliary cirrhosis	0.000982	0.00385	CcSEcCtD
Valsartan—Urticaria—Colchicine—primary biliary cirrhosis	0.000977	0.00383	CcSEcCtD
Valsartan—Dyspepsia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000972	0.00382	CcSEcCtD
Valsartan—Dyspepsia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000972	0.00382	CcSEcCtD
Valsartan—Abdominal pain—Colchicine—primary biliary cirrhosis	0.000972	0.00381	CcSEcCtD
Valsartan—Decreased appetite—Chenodeoxycholic acid—primary biliary cirrhosis	0.00096	0.00377	CcSEcCtD
Valsartan—Decreased appetite—Ursodeoxycholic acid—primary biliary cirrhosis	0.00096	0.00377	CcSEcCtD
Valsartan—Gastrointestinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000954	0.00374	CcSEcCtD
Valsartan—Gastrointestinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000954	0.00374	CcSEcCtD
Valsartan—Fatigue—Ursodeoxycholic acid—primary biliary cirrhosis	0.000952	0.00374	CcSEcCtD
Valsartan—Fatigue—Chenodeoxycholic acid—primary biliary cirrhosis	0.000952	0.00374	CcSEcCtD
Valsartan—AGTR1—Peptide ligand-binding receptors—CXCR5—primary biliary cirrhosis	0.000951	0.00759	CbGpPWpGaD
Valsartan—Constipation—Ursodeoxycholic acid—primary biliary cirrhosis	0.000945	0.00371	CcSEcCtD
Valsartan—Constipation—Chenodeoxycholic acid—primary biliary cirrhosis	0.000945	0.00371	CcSEcCtD
Valsartan—Hypersensitivity—Colchicine—primary biliary cirrhosis	0.000906	0.00356	CcSEcCtD
Valsartan—Gastrointestinal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000903	0.00355	CcSEcCtD
Valsartan—Gastrointestinal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000903	0.00355	CcSEcCtD
Valsartan—Asthenia—Colchicine—primary biliary cirrhosis	0.000882	0.00346	CcSEcCtD
Valsartan—Urticaria—Ursodeoxycholic acid—primary biliary cirrhosis	0.000877	0.00344	CcSEcCtD
Valsartan—Urticaria—Chenodeoxycholic acid—primary biliary cirrhosis	0.000877	0.00344	CcSEcCtD
Valsartan—Abdominal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000873	0.00343	CcSEcCtD
Valsartan—Abdominal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000873	0.00343	CcSEcCtD
Valsartan—AGTR1—Peptide ligand-binding receptors—CXCL9—primary biliary cirrhosis	0.000864	0.00689	CbGpPWpGaD
Valsartan—SLCO1B1—SLC-mediated transmembrane transport—SLC4A2—primary biliary cirrhosis	0.000858	0.00685	CbGpPWpGaD
Valsartan—CYP2C9—Constitutive Androstane Receptor Pathway—ABCC2—primary biliary cirrhosis	0.000854	0.00681	CbGpPWpGaD
Valsartan—Diarrhoea—Colchicine—primary biliary cirrhosis	0.000841	0.0033	CcSEcCtD
Valsartan—SLCO1B3—Bile acid and bile salt metabolism—ALB—primary biliary cirrhosis	0.000821	0.00655	CbGpPWpGaD
Valsartan—Hypersensitivity—Ursodeoxycholic acid—primary biliary cirrhosis	0.000814	0.00319	CcSEcCtD
Valsartan—Hypersensitivity—Chenodeoxycholic acid—primary biliary cirrhosis	0.000814	0.00319	CcSEcCtD
Valsartan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—primary biliary cirrhosis	0.000813	0.00649	CbGpPWpGaD
Valsartan—Asthenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000792	0.00311	CcSEcCtD
Valsartan—Asthenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000792	0.00311	CcSEcCtD
Valsartan—SLCO1B3—Transport of vitamins, nucleosides, and related molecules—ALB—primary biliary cirrhosis	0.000786	0.00627	CbGpPWpGaD
Valsartan—Vomiting—Colchicine—primary biliary cirrhosis	0.000782	0.00307	CcSEcCtD
Valsartan—Pruritus—Ursodeoxycholic acid—primary biliary cirrhosis	0.000781	0.00307	CcSEcCtD
Valsartan—Pruritus—Chenodeoxycholic acid—primary biliary cirrhosis	0.000781	0.00307	CcSEcCtD
Valsartan—AGTR1—Allograft Rejection—CD40LG—primary biliary cirrhosis	0.000779	0.00621	CbGpPWpGaD
Valsartan—Rash—Colchicine—primary biliary cirrhosis	0.000775	0.00304	CcSEcCtD
Valsartan—Dermatitis—Colchicine—primary biliary cirrhosis	0.000774	0.00304	CcSEcCtD
Valsartan—ALB—FOXA2 and FOXA3 transcription factor networks—IGFBP1—primary biliary cirrhosis	0.000771	0.00616	CbGpPWpGaD
Valsartan—Headache—Colchicine—primary biliary cirrhosis	0.00077	0.00302	CcSEcCtD
Valsartan—AGTR1—Allograft Rejection—IL4—primary biliary cirrhosis	0.000757	0.00604	CbGpPWpGaD
Valsartan—Diarrhoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000756	0.00297	CcSEcCtD
Valsartan—Diarrhoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000756	0.00297	CcSEcCtD
Valsartan—AGTR1—GPCRs, Class A Rhodopsin-like—CXCR5—primary biliary cirrhosis	0.000745	0.00594	CbGpPWpGaD
Valsartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—MMP2—primary biliary cirrhosis	0.000739	0.00589	CbGpPWpGaD
Valsartan—Dizziness—Chenodeoxycholic acid—primary biliary cirrhosis	0.00073	0.00287	CcSEcCtD
Valsartan—Dizziness—Ursodeoxycholic acid—primary biliary cirrhosis	0.00073	0.00287	CcSEcCtD
Valsartan—Nausea—Colchicine—primary biliary cirrhosis	0.00073	0.00287	CcSEcCtD
Valsartan—Vomiting—Chenodeoxycholic acid—primary biliary cirrhosis	0.000702	0.00276	CcSEcCtD
Valsartan—Vomiting—Ursodeoxycholic acid—primary biliary cirrhosis	0.000702	0.00276	CcSEcCtD
Valsartan—Rash—Ursodeoxycholic acid—primary biliary cirrhosis	0.000696	0.00273	CcSEcCtD
Valsartan—Rash—Chenodeoxycholic acid—primary biliary cirrhosis	0.000696	0.00273	CcSEcCtD
Valsartan—Dermatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000696	0.00273	CcSEcCtD
Valsartan—Dermatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000696	0.00273	CcSEcCtD
Valsartan—Headache—Ursodeoxycholic acid—primary biliary cirrhosis	0.000692	0.00272	CcSEcCtD
Valsartan—Headache—Chenodeoxycholic acid—primary biliary cirrhosis	0.000692	0.00272	CcSEcCtD
Valsartan—SLCO1B3—Metabolism of lipids and lipoproteins—LBR—primary biliary cirrhosis	0.000683	0.00545	CbGpPWpGaD
Valsartan—Nausea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000656	0.00258	CcSEcCtD
Valsartan—Nausea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000656	0.00258	CcSEcCtD
Valsartan—SLCO1B3—Transmembrane transport of small molecules—SLC4A2—primary biliary cirrhosis	0.000649	0.00518	CbGpPWpGaD
Valsartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCR5—primary biliary cirrhosis	0.000638	0.00509	CbGpPWpGaD
Valsartan—ALB—Binding and Uptake of Ligands by Scavenger Receptors—COL1A1—primary biliary cirrhosis	0.000633	0.00505	CbGpPWpGaD
Valsartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL9—primary biliary cirrhosis	0.000579	0.00462	CbGpPWpGaD
Valsartan—AGTR1—Allograft Rejection—CD80—primary biliary cirrhosis	0.000579	0.00462	CbGpPWpGaD
Valsartan—Losartan—ALB—primary biliary cirrhosis	0.000572	0.116	CrCbGaD
Valsartan—SLCO1B1—Bile acid and bile salt metabolism—ALB—primary biliary cirrhosis	0.000552	0.0044	CbGpPWpGaD
Valsartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—NFKB1—primary biliary cirrhosis	0.000549	0.00438	CbGpPWpGaD
Valsartan—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—ALB—primary biliary cirrhosis	0.000528	0.00422	CbGpPWpGaD
Valsartan—ALB—SLC-mediated transmembrane transport—SLC4A2—primary biliary cirrhosis	0.00049	0.00391	CbGpPWpGaD
Valsartan—AGTR1—GPCR ligand binding—CXCR5—primary biliary cirrhosis	0.000486	0.00388	CbGpPWpGaD
Valsartan—CYP2C9—Constitutive Androstane Receptor Pathway—PPARGC1A—primary biliary cirrhosis	0.000474	0.00378	CbGpPWpGaD
Valsartan—SLCO1B3—SLC-mediated transmembrane transport—NUP210—primary biliary cirrhosis	0.000465	0.00371	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—LBR—primary biliary cirrhosis	0.000459	0.00366	CbGpPWpGaD
Valsartan—AGTR1—Peptide ligand-binding receptors—CXCL10—primary biliary cirrhosis	0.00045	0.00359	CbGpPWpGaD
Valsartan—AGTR1—GPCR ligand binding—CXCL9—primary biliary cirrhosis	0.000441	0.00352	CbGpPWpGaD
Valsartan—SLCO1B1—Transmembrane transport of small molecules—SLC4A2—primary biliary cirrhosis	0.000436	0.00348	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism of lipids and lipoproteins—ABCB4—primary biliary cirrhosis	0.000414	0.0033	CbGpPWpGaD
Valsartan—AGTR1—Peptide ligand-binding receptors—CCL5—primary biliary cirrhosis	0.000387	0.00309	CbGpPWpGaD
Valsartan—CYP2C9—Arachidonic acid metabolism—GGT1—primary biliary cirrhosis	0.000373	0.00298	CbGpPWpGaD
Valsartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—primary biliary cirrhosis	0.000372	0.00297	CbGpPWpGaD
Valsartan—ALB—Vitamin B12 Metabolism—CCL5—primary biliary cirrhosis	0.000372	0.00297	CbGpPWpGaD
Valsartan—AGTR1—G alpha (q) signalling events—AGT—primary biliary cirrhosis	0.000328	0.00262	CbGpPWpGaD
Valsartan—AGTR1—Peptide ligand-binding receptors—AGT—primary biliary cirrhosis	0.000324	0.00259	CbGpPWpGaD
Valsartan—SLCO1B1—SLC-mediated transmembrane transport—NUP210—primary biliary cirrhosis	0.000312	0.00249	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—LBR—primary biliary cirrhosis	0.000304	0.00243	CbGpPWpGaD
Valsartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL10—primary biliary cirrhosis	0.000302	0.00241	CbGpPWpGaD
Valsartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—primary biliary cirrhosis	0.000293	0.00234	CbGpPWpGaD
Valsartan—ALB—Folate Metabolism—IL4—primary biliary cirrhosis	0.000293	0.00234	CbGpPWpGaD
Valsartan—ALB—Selenium Micronutrient Network—GGT1—primary biliary cirrhosis	0.00029	0.00231	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—ABCB4—primary biliary cirrhosis	0.000278	0.00222	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—CXCR5—primary biliary cirrhosis	0.000275	0.00219	CbGpPWpGaD
Valsartan—SLCO1B3—Transmembrane transport of small molecules—AQP4—primary biliary cirrhosis	0.00027	0.00215	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—LBR—primary biliary cirrhosis	0.000262	0.00209	CbGpPWpGaD
Valsartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL5—primary biliary cirrhosis	0.00026	0.00207	CbGpPWpGaD
Valsartan—SLCO1B3—Transmembrane transport of small molecules—ABCC2—primary biliary cirrhosis	0.000258	0.00206	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—CXCR5—primary biliary cirrhosis	0.000249	0.00199	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—CXCL9—primary biliary cirrhosis	0.000249	0.00199	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—SLC4A2—primary biliary cirrhosis	0.000249	0.00199	CbGpPWpGaD
Valsartan—SLCO1B3—Transmembrane transport of small molecules—NUP210—primary biliary cirrhosis	0.000236	0.00189	CbGpPWpGaD
Valsartan—AGTR1—GPCR ligand binding—CXCL10—primary biliary cirrhosis	0.00023	0.00183	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—CXCL9—primary biliary cirrhosis	0.000226	0.00181	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—OGDH—primary biliary cirrhosis	0.00022	0.00175	CbGpPWpGaD
Valsartan—SLCO1B3—Transmembrane transport of small molecules—ABCG2—primary biliary cirrhosis	0.00022	0.00175	CbGpPWpGaD
Valsartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—primary biliary cirrhosis	0.000219	0.00175	CbGpPWpGaD
Valsartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—AGT—primary biliary cirrhosis	0.000217	0.00173	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—LBR—primary biliary cirrhosis	0.000214	0.00171	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—LBR—primary biliary cirrhosis	0.000204	0.00163	CbGpPWpGaD
Valsartan—ALB—Hemostasis—RAD51B—primary biliary cirrhosis	0.000199	0.00159	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	0.000198	0.00158	CbGpPWpGaD
Valsartan—AGTR1—GPCR ligand binding—CCL5—primary biliary cirrhosis	0.000198	0.00158	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—PDHX—primary biliary cirrhosis	0.000196	0.00156	CbGpPWpGaD
Valsartan—ALB—Hemostasis—PDE5A—primary biliary cirrhosis	0.000185	0.00148	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—ABCB4—primary biliary cirrhosis	0.000184	0.00147	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—DLAT—primary biliary cirrhosis	0.000184	0.00147	CbGpPWpGaD
Valsartan—ALB—Vitamin B12 Metabolism—NFKB1—primary biliary cirrhosis	0.000181	0.00145	CbGpPWpGaD
Valsartan—SLCO1B1—Transmembrane transport of small molecules—AQP4—primary biliary cirrhosis	0.000181	0.00145	CbGpPWpGaD
Valsartan—ALB—SLC-mediated transmembrane transport—NUP210—primary biliary cirrhosis	0.000179	0.00142	CbGpPWpGaD
Valsartan—SLCO1B1—Transmembrane transport of small molecules—ABCC2—primary biliary cirrhosis	0.000174	0.00139	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	0.00017	0.00135	CbGpPWpGaD
Valsartan—SLCO1B3—SLC-mediated transmembrane transport—ALB—primary biliary cirrhosis	0.000169	0.00135	CbGpPWpGaD
Valsartan—AGTR1—GPCR ligand binding—AGT—primary biliary cirrhosis	0.000165	0.00132	CbGpPWpGaD
Valsartan—SLCO1B1—Transmembrane transport of small molecules—NUP210—primary biliary cirrhosis	0.000159	0.00127	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—ABCB4—primary biliary cirrhosis	0.000159	0.00127	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CDH5—primary biliary cirrhosis	0.000153	0.00122	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	0.000151	0.0012	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—OGDH—primary biliary cirrhosis	0.000148	0.00118	CbGpPWpGaD
Valsartan—SLCO1B1—Transmembrane transport of small molecules—ABCG2—primary biliary cirrhosis	0.000148	0.00118	CbGpPWpGaD
Valsartan—ALB—Folate Metabolism—NFKB1—primary biliary cirrhosis	0.000147	0.00118	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CXCR5—primary biliary cirrhosis	0.000147	0.00118	CbGpPWpGaD
Valsartan—CYP2C9—Biological oxidations—GGT1—primary biliary cirrhosis	0.000139	0.00111	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CXCL9—primary biliary cirrhosis	0.000134	0.00107	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	0.000133	0.00106	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—PDHX—primary biliary cirrhosis	0.000132	0.00105	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—ABCB4—primary biliary cirrhosis	0.00013	0.00104	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—CXCL10—primary biliary cirrhosis	0.00013	0.00104	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—ELMO1—primary biliary cirrhosis	0.000124	0.000988	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—ABCB4—primary biliary cirrhosis	0.000124	0.000988	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—DLAT—primary biliary cirrhosis	0.000124	0.000988	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—CXCL10—primary biliary cirrhosis	0.000118	0.000941	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	0.000118	0.000938	CbGpPWpGaD
Valsartan—ALB—Selenium Micronutrient Network—NFKB1—primary biliary cirrhosis	0.000117	0.000934	CbGpPWpGaD
Valsartan—ALB—Metabolism—LBR—primary biliary cirrhosis	0.000117	0.000931	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	0.000114	0.000909	CbGpPWpGaD
Valsartan—SLCO1B1—SLC-mediated transmembrane transport—ALB—primary biliary cirrhosis	0.000113	0.000905	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—CCL5—primary biliary cirrhosis	0.000112	0.000892	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—NUP210—primary biliary cirrhosis	0.000111	0.000883	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—MMP3—primary biliary cirrhosis	0.000108	0.000858	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—AQP4—primary biliary cirrhosis	0.000103	0.000826	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—ABCG2—primary biliary cirrhosis	0.000103	0.000821	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—CCL5—primary biliary cirrhosis	0.000102	0.00081	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	0.000101	0.000809	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—ABCC2—primary biliary cirrhosis	9.92e-05	0.000792	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—LBR—primary biliary cirrhosis	9.55e-05	0.000762	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—AGT—primary biliary cirrhosis	9.35e-05	0.000746	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—NUP210—primary biliary cirrhosis	9.07e-05	0.000724	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	9.02e-05	0.00072	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—CTGF—primary biliary cirrhosis	8.83e-05	0.000705	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—GOT2—primary biliary cirrhosis	8.75e-05	0.000698	CbGpPWpGaD
Valsartan—SLCO1B3—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	8.58e-05	0.000685	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—AGT—primary biliary cirrhosis	8.49e-05	0.000678	CbGpPWpGaD
Valsartan—ALB—Metabolism—OGDH—primary biliary cirrhosis	8.44e-05	0.000673	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—ABCG2—primary biliary cirrhosis	8.43e-05	0.000673	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	7.9e-05	0.00063	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	7.61e-05	0.000607	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—GOT1—primary biliary cirrhosis	7.55e-05	0.000603	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—GGT1—primary biliary cirrhosis	7.55e-05	0.000603	CbGpPWpGaD
Valsartan—ALB—Metabolism—PDHX—primary biliary cirrhosis	7.52e-05	0.0006	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—NUP210—primary biliary cirrhosis	7.44e-05	0.000594	CbGpPWpGaD
Valsartan—ALB—Metabolism—ABCB4—primary biliary cirrhosis	7.07e-05	0.000564	CbGpPWpGaD
Valsartan—ALB—Metabolism—DLAT—primary biliary cirrhosis	7.07e-05	0.000564	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CXCL10—primary biliary cirrhosis	6.97e-05	0.000556	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—ABCG2—primary biliary cirrhosis	6.91e-05	0.000552	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—OGDH—primary biliary cirrhosis	6.91e-05	0.000551	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—PPARGC1A—primary biliary cirrhosis	6.72e-05	0.000536	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	6.51e-05	0.00052	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—MMP3—primary biliary cirrhosis	6.35e-05	0.000507	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—TYK2—primary biliary cirrhosis	6.35e-05	0.000507	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	6.23e-05	0.000497	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—PDHX—primary biliary cirrhosis	6.16e-05	0.000491	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	6.06e-05	0.000484	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CCL5—primary biliary cirrhosis	6e-05	0.000479	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—CTGF—primary biliary cirrhosis	5.93e-05	0.000473	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—GOT2—primary biliary cirrhosis	5.88e-05	0.000469	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	5.81e-05	0.000464	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	5.79e-05	0.000462	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—DLAT—primary biliary cirrhosis	5.79e-05	0.000462	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ABCB4—primary biliary cirrhosis	5.79e-05	0.000462	CbGpPWpGaD
Valsartan—SLCO1B1—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	5.76e-05	0.00046	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	5.33e-05	0.000425	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—AGT—primary biliary cirrhosis	5.24e-05	0.000418	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—GOT1—primary biliary cirrhosis	5.07e-05	0.000405	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—GGT1—primary biliary cirrhosis	5.07e-05	0.000405	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—HIF1A—primary biliary cirrhosis	5.04e-05	0.000402	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—AGT—primary biliary cirrhosis	5.02e-05	0.0004	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	4.74e-05	0.000378	CbGpPWpGaD
Valsartan—ALB—Hemostasis—NOS2—primary biliary cirrhosis	4.53e-05	0.000361	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—PPARGC1A—primary biliary cirrhosis	4.52e-05	0.00036	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	4.51e-05	0.00036	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CD80—primary biliary cirrhosis	4.44e-05	0.000355	CbGpPWpGaD
Valsartan—ALB—Metabolism—NUP210—primary biliary cirrhosis	4.25e-05	0.000339	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—ALB—primary biliary cirrhosis	4.02e-05	0.000321	CbGpPWpGaD
Valsartan—ALB—Metabolism—ABCG2—primary biliary cirrhosis	3.95e-05	0.000315	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—TYK2—primary biliary cirrhosis	3.75e-05	0.000299	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	3.69e-05	0.000295	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—AGT—primary biliary cirrhosis	3.52e-05	0.000281	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—NUP210—primary biliary cirrhosis	3.48e-05	0.000278	CbGpPWpGaD
Valsartan—ALB—Metabolism—CTGF—primary biliary cirrhosis	3.39e-05	0.00027	CbGpPWpGaD
Valsartan—ALB—Metabolism—GOT2—primary biliary cirrhosis	3.36e-05	0.000268	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ABCG2—primary biliary cirrhosis	3.23e-05	0.000258	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—MMP9—primary biliary cirrhosis	2.95e-05	0.000236	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—NFKB1—primary biliary cirrhosis	2.92e-05	0.000233	CbGpPWpGaD
Valsartan—ALB—Metabolism—GOT1—primary biliary cirrhosis	2.9e-05	0.000231	CbGpPWpGaD
Valsartan—ALB—Metabolism—GGT1—primary biliary cirrhosis	2.9e-05	0.000231	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	2.83e-05	0.000226	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—CTGF—primary biliary cirrhosis	2.77e-05	0.000221	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—GOT2—primary biliary cirrhosis	2.75e-05	0.000219	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—ALB—primary biliary cirrhosis	2.7e-05	0.000215	CbGpPWpGaD
Valsartan—ALB—Metabolism—PPARGC1A—primary biliary cirrhosis	2.58e-05	0.000206	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—GGT1—primary biliary cirrhosis	2.37e-05	0.000189	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—GOT1—primary biliary cirrhosis	2.37e-05	0.000189	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—PPARGC1A—primary biliary cirrhosis	2.11e-05	0.000169	CbGpPWpGaD
Valsartan—ALB—Metabolism—AGT—primary biliary cirrhosis	2.01e-05	0.00016	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—AGT—primary biliary cirrhosis	1.64e-05	0.000131	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ALB—primary biliary cirrhosis	1.26e-05	0.000101	CbGpPWpGaD
